Biogen’s Plea To Medicare: Just Cover The Aduhelm Clinical Trial Population
Executive Summary
Company discusses its strategy for negotiating a change in the recently-proposed Medicare coverage decision for Alzheimer’s drugs during a presentation to analysts.